Patent Number definition

Patent Number means a reference number identifying a patent.
Sample 1Sample 2Sample 3
Patent Number. [*] PCT Patent Number: [*]
Sample 1
Patent Number. 2019131 Date Granted and Issued: October 29, 1996 XXXXXX XXXXXX XXXISTRATION: Patent Number: 5,086,402 Date Granted and Issued: February 4, 1992 48 6 (ii) Other than the trade-mark Xxxositions and Section 45 actions to which Simware Inc. is a party (as disclosed in the following tables), there are no other proceedings or actions before any court, tribunal (including the United States Patent and Trademark Office ("PTO") or equivalent authority anywhere in the world) related to any Company Intellectual Property. PROCEEDINGS INITIATED BY THE CORPORATION I. OPPOSITIONS BY SIMWARE INC. CANADA (ACTIVE) TRADE-MARK & SERIAL NO. STATUS OF TAB APPLICANT & FILING DATE OPPOSITION --- ---------------- ------------- ---------- 65. OSIM & Design 855,156 Rule 42 evidence due Originalsim Inc. September 4, 1997 Applicants deadline: October 19, 1999 66. ORIGINALSIM 847,228 Rule 42 evidence due Originalsim Inc. June 6, 1997 Applicants deadline: October 19, 1999 67. SIMEX 848,389 Rule 41 evidence due ANDREAS RU(beta) June 18, 1997 Opponent's deadline: November 28, 1999
Sample 1

Examples of Patent Number in a sentence

  • Yin, European Patent Council, US, 9743238.9, filed 9/16/2010; Japanese Patent Number 5796881 (8/28/2015).

  • J.; Baker, D.; Johnson, Edward (Merle); Yin, Wenyuan, US Utility Patent, Serial# 12/367,867, Filed 2/9/2009, Issued 5/8/2013; Patent Number: 8,173,809.

  • J.; Baker, D.; Johnson, E.; Yin, W., US Patent, Divisonal, Serial number 13/465,383; Filed 5/7/2012; Patent Number: 8,962,692.

  • Yin, 13/465,383, filed 5/7/2012; Patent Number: 8962,692, Issued 2/24/2015.

  • The nitrogen sealed glass containers preserve the freshness of the flower and essential terpenes to improve the “entourage effect.” The USPTO issued Grown Rogue United States Patent Number 10,358,282 on July 23, 2019.

  • IDT is licensed under U.S Patent Number 6,180,770 and 5,932,711 to sell this product for use solely in the purchaser’s own life sciences research and development activities.

  • Concealed panel alignment with a tight seal through the patented (Patent Number: US10711510B2) TwinX mechanism reinforced between panels.

  • Gilead hereby grants Isis an exclusive, royalty-free, worldwide, assignable license (with the right to grant sublicenses) to U.S. Patent Number 5,256,775 beginning on the Effective Date and continuing until such time that Gilead settles the interference and the assignment to Isis becomes effective.

  • On November 9, 2010 the Canadian Intellectual Property Office issued Patent Number 2,624,110 to Dr. Modi for his wafer formulation.

  • On January 7, 2014 the United States Patent and Trademark Office issued Patent Number 8,623,401 B2 to Pankaj Modi for his wafer formulation.


More Definitions of Patent Number

Patent Number. Application Serial Number: Issued or Published? Issue Date:
Sample 1
Patent Number. Sub Sta Abandon Date Grant Date BP6322 U.S.A. 10 Sep 1986 905543 ABN 01 Jan 1989 BP6322A PHILIPPINES 10 Sep 1987 35798 XXX XX0000X XXXXXX 08 Sep 1987 546354 XXX XX0000X XXXXXXXXX 10 Sep 1987 87/078224 607935 ISS 01 Aug 1991 BP6322A ISRAEL 09 Sep 1987 83842 83842 ISS 02 Oct 1991 BP6322A MALAYSIA 10 Sep 1987 XX0000000 MY101368A ISS 05 Sep 1991 BP6322A DENMARK 09 Sep 1987 87/004700 169071 ISS 08 Aug 1994 BP6322A IRELAND 09 Sep 1987 87/002406 60423 ISS 08 Jul 1994 BP6322A KOREA SOUTH 10 Sep 1987 87/010028 107765 ISS 15 Nov 1996 BP6322A HUNGARY 09 Sep 1987 87/004018 198016 ISS 19 Apr 1989 BP6322A PORTUGAL 09 Sep 1987 85668 85668 XXX 00 Xxx 0000 XX0000X XXXXX 09 Sep 1987 87/224204 2110963 ISS 21 Nov 1996 BP6322A EUR PATENT 05 Sep 1987 87113010.0 0260555 ISS 22 Apr 1992 BP6322A BELGIUM 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A FRANCE 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREAT BRITAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A ITALY 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A LUXEMBOURG 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A NETHERLANDS 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SPAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWEDEN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWITZERLAND 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREECE 05 Sep 1987 UNKN 3004962 ISS 22 Apr 1992 BP6322A GERMANY 05 Sep 1987 P3778463.3-08 3778463 ISS 22 Apr 1992 BP6322A AUSTRIA 05 Sep 1987 UNKN E0075223 ISS 22 Apr 1992 Docket Number Country Name Appl. Date Applic. Number Patent Number Sub Sta Abandon Date Grant Date BP6322A RUSSIAN FED 09 Sep 1987 4203411/04 1582984 ISS 23 Dec 1988 BP6322A U.S.A. 16 Jul 1987 07/071028 4876269 ISS 24 Oct 1989 BP6322A FINLAND 09 Sep 1987 87/003896 88298 ISS 26 Apr 1993 BP6322A MEXICO 10 Sep 1987 008173 170515 ISS 27 Aug 1993 BP6322A NEW ZEALAND 08 Sep 1987 221726 221726 ISS 28 Aug 1990 BP6322A NORWAY 09 Sep 1987 87/003762 172934 ISS 29 Sep 1993 XX0000X XXXXX XXXXXX 10 Sep 1987 87/006778 87/006778 ISS 30 May 1989 BP6322A TAIWAN 09 Sep 1987 76105341 031661 ISS 31 Jul 1989 DuPont Legal Patent Division License Agreement: NorthStar & Endo Pharmaceuticals DuP 769 Exhibit A 27 October 1997
Sample 1
Patent Number. Sub Sta Abandon Date Grant Date BP6295 U.S.A. 02 Dec 1985 803222 4722928 ABN 02 Aug 1995 02 Feb 1988 BP6295 JAPAN 01 Dec 1986 86/284459 1966196 ISS 25 Aug 1995 BP6295 1 JAPAN 24 May 1993 93/121382 2017591 ISS 19 Feb 1996 BP6295A U.S.A. 01 Oct 1987 07/103213 ABN 01 Aug 1989 BP6295B U.S.A. 27 Jul 1989 07/391406 4990617 ISS 05 Feb 1991
Sample 1
Patent Number. 2154609 Title: HCMV Monocolonal Antibodies and their use in infection of HCMV injection and HCMV Specific IGM, methods of detect ING viral antigens Country: United Kingdom Next Renewal Due: 18 February 1998
Sample 1

Related to Patent Number

  • Relevant Number means the number specified as such in the applicable Final Terms (or, if no such number is specified, five);

  • Patent Application means an application for patent protection for a CRADA Subject Invention with the United States Patent and Trademark Office (“U.S.P.T.O.”) or the corresponding patent-issuing authority of another nation.

  • Commercial User means all retail stores, restaurants, office buildings, laundries, and other private business and service establishments.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Contract Number means, with respect to any Contract included in the Trust, the number assigned to such Contract by the Servicer, which number is set forth in the related Schedule of Contracts.

  • CT number means the number used to represent the x-ray attenuation associated with each elemental area of the CT image.

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • Commercial Use means the use to which the material can commercially be put.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Patent Family means all patents and patent applications that share a common priority application, excluding continuations in part, but including any divisionals, continuations, reissues, reexaminations, extensions, foreign counterparts or equivalents. For the avoidance of doubt, if any patent or patent application is subject to a terminal disclaimer with any other patent or patent application such patent or patent application and such other patent or patent application shall be deemed one (1) Patent Family for the purposes of this Agreement.

  • Regents' Patent Rights means REGENTS' rights in (a) the patent and patent applications expressly identified in Appendix C and their foreign counterparts;

  • Lot number or “batch number” means a distinctive group of numbers, letters, or symbols or any combination of these that is unique to a group of cannabis goods.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or restoration by existing or future extension or restoration mechanisms (including, without limitation, supplementary protection certificates or the equivalent thereof), or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Adjustment Number shall initially be 10,000. In the event the Corporation shall at any time after November 5, 1998 (i) declare or pay any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock into a greater number of shares or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the Adjustment Number in effect immediately prior to such event shall be adjusted by multiplying such Adjustment Number by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

  • Joint Inventions has the meaning set forth in Section 9.1.

  • Grant Number CA0244L9T101912 Tax ID Number: 00-0000000 DUNS Number: 149816360

  • Joint Invention has the meaning set forth in Section 9.1.

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Commercial Software means Software developed or regularly used that: (i) has been sold, leased, or licensed to the general public; (ii) has been offered for sale, lease, or license to the general public; (iii) has not been offered, sold, leased, or licensed to the public but will be available for commercial sale, lease, or license in time to satisfy the delivery requirements of this Contract; or (iv) satisfies a criterion expressed in (i), (ii), or (iii) above and would require only minor modifications to meet the requirements of this Contract.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Product Patents means any and all United States patents and patent applications, all divisionals, continuations, continuations-in-part, re-issues, extensions or foreign counterparts thereof, now or hereafter owned or controlled ("controlled" being used in the sense of having the right to grant licenses thereunder) by PERIMMUNE, covering the manufacture, use, sale, offer for sale and/or importation of the Product, including but not limited to, the U.S. Patent No. 5,407,912 attached hereto as Exhibit B.

  • Client Application means an application developed by Licensee that a) utilizes the Runtime Product, b) is installed fully on an end user’s machine, with all report processing local to that machine, and c) adds significant and primary functionality to the Runtime Product.

  • Joint Patents means all Patents claiming any Joint Invention.

  • Background Invention means an Invention conceived and first actually reduced to practice before the Effective Date.

  • Program Patents has the meaning set forth in Section 7.1.2.